-
Breaking the Blood-Brain BarrierAdvances in treating brain metastases and reducing their side effects are bringing new hope to cancer patients.
by Sue Rochman
-
Colorectal Cancer: A Troubling TrendMore people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
-
Healthy Habits
Pile on the VeggiesA study evaluates whether a change in diet could slow prostate cancer growth.
by Melinda Mahaffey Icden
-
Healthy Habits
Nothing Healthy About a TanThe CDC calls for community efforts to halt rising rates of melanoma.
by Brenda Conaway
-
From the Editor-in-Chief
The Immune System and CancerNew insights into how the immune system can be unleashed are driving new treatments.
by William G. Nelson, MD, PhD
-
Forward Look
Your Neighborhood, YourselfQ&A with Reginald Tucker-Seeley on the link between neighborhoods and cancer.
by Sue Rochman
-
Forward Look
The Right MatchNew NCI clinical trial will link patients to drugs that target their tumors.
by Whitney L.J. Howell
-
From the Editor-in-Chief
Inheritance, ‘Bad Luck’ and the EnvironmentWhy do some people develop cancer while others do not?
by William G. Nelson, MD, PhD
-
Forward Look
There Goes the NeighborhoodQ&A with scientist Zena Werb on cancer, immunity and the microenvironment.
by Chris Palmer
-
Forward Look
Cost of Breast Cancer Treatment Affects AdherenceDrug for early-stage cancer must be taken for many years to be effective.
by Kendall K. Morgan
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
